BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Register
Register
Register

ProjectUpdated on 11 August 2026

2Health AI

CEO at Gene to Health Limited

China (Hong Kong)

About

Gene to Health Limited (https://gene2h.com) have launched the G2H system embodying broad-spectrum disease-risk prediction models trained on health data from over one million people, which integrates DNA data, health check reports, and medical records to generate risk scores for over a thousand diseases. Its spin-off, 2Health AI Limited (https://2health.cn), has recently developed the world's first comprehensive multi-omics and AI-driven personal health digital twin platform, 2HEALTH AI (2HAI). It integrates genomic, metabolomic, physical-exam, clinical, wearable, home-device and lifestyle data into a continuously-updated personal health profile spanning the entire life cycle. Powered by the G2H system, plus an intelligent analytics engine and AI health advisors, 2HAI delivers lifelong health-data management, long-term risk assessment across hundreds of diseases, personalized recommendations, secondary report interpretation, lifestyle intervention, biological-age and life-expectancy estimation, and connection to medical services. The platform offer interfaces also to doctors and suppliers, helping connect them with individuals and families in a large ecosystem of healthcare products and services. The platform is already live at 2health.ai and is being put into pilot use as Digital Public Infrastructure for Health (DPI-H) in the ASEAN market.

Project Location

  • China (Hong Kong)

Project Website

https://2health.cn

Project Format

  • Public-Private Partnership Project

Go Global Project

  • No

ESG (Environmental, Social, and Governance)

  • Yes

Project Stage

  • Investment / Financing Discussion

Main Project Sector

  • Public Utilities
  • Technology

Public Utilities

  • ICT And Data Center

Technology

  • Bio-Tech
  • Fin-Tech
  • Health Technology
  • Medical Technology

Total Project Value

  • 1,000,001 to 2,500,000 USD

Investment Capital Required

  • 2,500,001 to 5,000,000 USD

Interested Format of Cooperation

  • Direct Equity Investment
  • Joint Venture

Preferred Financing Model

  • Equity

Type(s) of Last Financing Round of the project (if Applicable)

  • Venture Capital (VC)

Main Service(s) Required

  • Financial Services

Financial Services

  • Investment Banking
  • Private Equity & Venture Capital

Professional Services

  • Business Valuation

Organisation

Gene to Health Limited

China (Hong Kong)

Similar opportunities